H. Herz et al., Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature, ANN ONCOL, 11(10), 2000, pp. 1343-1347
Secretory carcinoma of the breast is a rare and indolent tumour originally
described in children but occurring equally in the adult population. The pr
incipal management problems following primary surgical treatment are local
recurrence and axillary lymph node metastases. Distant metastases are extre
mely rare.
We present the case of a 27-year-old woman with pulmonary metastases from a
secretory breast cancer treated by mastectomy and axillary lymph node diss
ection 12 years previously.
There was no response to chemotherapy; however, the patient remained alive
and active two years from presentation with metastatic disease and one year
from cessation of all cytotoxic chemotherapy. She eventually died of respi
ratory failure two and a half years after presentation.
To our knowledge, this is only the fourth reported case of distant metastas
es from secretory breast cancer and the second reported case in which curre
nt active chemotherapy has been used. We review the literature and discuss
the apparent chemoresistance of this tumour including the lack of membrane
staining for Her2/neu.
In the absence of any proven effective chemotherapy we believe that symptom
control becomes the focus of management and offers patients with metastati
c secretory breast cancer the greatest chance of a functional and good qual
ity existence.